header logo image

Roche Restructuring Shows Trouble in US Diabetes Biz (RHHBY) – Investopedia

March 18th, 2017 3:44 am

Investopedia
Roche Restructuring Shows Trouble in US Diabetes Biz (RHHBY)
Investopedia
Amid increasing competition in the U.S. diabetes care market, Roche AG (RHHBY) plans to restructure its U.S. operations and reduce headcount by 10%. The company recently announced that it will lay off 157 employees in its U.S. diabetes care unit.

Visit link:
Roche Restructuring Shows Trouble in US Diabetes Biz (RHHBY) - Investopedia

Related Post

Comments are closed.


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick